Tradestie Institutional Equity Comparison Engine

AGEN vs ARIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AGEN Overall Edge

AGEN Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Agenus Inc. (AGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AGEN trades at 3.7x Forward P/E with 38.9% operating margin (+4.1% YoY revenue) versus ARIA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AGEN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AGEN
AGEN 3.7x vs ARIA N/M Fwd P/E
Growth & Margin Winner AGEN
Op Margin 38.9% vs N/A ยท YoY +4.1% vs N/A
Momentum & Technical Winner AGEN
1Y +45.3% vs -17.0% ยท 52W Pos 47% vs 0%
Options & Structure Winner AGEN
BREAKDOWN (13th %ile IV) vs UNCLASSIFIED (N/A IV)
AGEN NASDAQ
Agenus Inc.
Biological Products, (No Disgnostic Substances)
$6.29
-6.54% 1D
Market Cap $304.5M
1M Return +4.14%
1Y Return +45.27%
Forward P/E 3.7x
Unified AI Score
52.4 / 100 HOLD
Tech 44.0 Fund 53.0 Flow 66.0 Mom 50.0
ARIA US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap N/A
1M Return -11.55%
1Y Return -16.97%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AGEN +45.27% ARIA -16.97% Spread: +6.83 pp (AGEN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AGEN TTM Op. Margin: 38.9% ARIA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AGEN vs ARIA. Trailing 12-month operating profitability (AGEN 38.9% vs ARIA N/A) and valuation multiples (AGEN 3.7x vs ARIA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AGEN (9) vs ARIA (1)
Institutional Metric AGEN ARIA Criterion Row Winner
Market Capitalization Scale $304.5M N/A Larger Scale AGEN
Trailing P/E Ratio Valuation 29.3x N/M Lower Multiple AGEN
Forward P/E Ratio Valuation 3.7x N/M Lower Multiple AGEN
Revenue Growth (YoY) Growth +4.1% N/A Higher Growth AGEN
Operating Margin (TTM) Profitability 38.9% N/A Higher Margin AGEN
Net Profit Margin Profitability 30.8% N/A Higher Margin AGEN
Return on Equity (ROE) Capital Efficiency -1278.8% N/A Higher ROE AGEN
52-Week Range Position Momentum 47% ($3โ€“$10) 0% ($21โ€“$27) Stronger Trend AGEN
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 76% Vol 1.92ฮฒ ยท 43% Vol Lower Realized Risk ARIA
Unified Institutional Score Composite Signal 52.4 / 100 (HOLD) 47.7 / 100 (HOLD) Higher Composite AGEN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AGEN vs ARIA Buy Guide
AGEN BREAKDOWN
33d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live AGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ARIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AGEN nor ARIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.